Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early-Stage Breast Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00003893
What this trial is testing

Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
University Hospital Birmingham 2,250
Testing effectiveness (Phase 2)UnknownNCT04996836
What this trial is testing

Breast Cancer, Omics, and Precision Medicine

Who this might be right for
Breast Cancer
University of Campania Luigi Vanvitelli 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04293393
What this trial is testing

Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients

Who this might be right for
Early Breast Cancer
Spanish Breast Cancer Research Group 200
Testing effectiveness (Phase 2)Looking for participantsNCT07327021
What this trial is testing

MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC

Who this might be right for
TNBC, Triple Negative Breast CancerEarly Breast Cancer
Tel-Aviv Sourasky Medical Center 54
Not applicableLooking for participantsNCT06885671
What this trial is testing

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
British Columbia Cancer Agency 60
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Very early researchEnded earlyNCT02380209
What this trial is testing

An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
University of Arizona 8
Testing effectiveness (Phase 2)UnknownNCT04739670
What this trial is testing

Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast Cancer
Peter MacCallum Cancer Centre, Australia 31
Large-scale testing (Phase 3)Looking for participantsNCT06839001
What this trial is testing

CRYoablation for Small Tumors As Local Treatment - SIX Trial

Who this might be right for
Breast CancerBreast Neoplasm
Hospital do Coracao 750
Testing effectiveness (Phase 2)UnknownNCT03906669
What this trial is testing

A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.

Who this might be right for
Early-stage Breast CancerHormone Receptor Positive Tumor
St Vincent's Hospital 200
Large-scale testing (Phase 3)Ended earlyNCT00543127
What this trial is testing

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 870
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Not applicableStudy completedNCT03946683
What this trial is testing

Cyberknife for Early Stage Breast Cancer

Who this might be right for
Early Stage Breast Cancer
NYU Langone Health 26
Testing effectiveness (Phase 2)Ended earlyNCT03499353
What this trial is testing

Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

Who this might be right for
Early Breast Cancer
Pfizer 61
Post-approval studies (Phase 4)Study completedNCT00742222
What this trial is testing

Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer

Who this might be right for
Breast CancerCarcinomaLumpectomy+1 more
Xoft, Inc. 63
Testing effectiveness (Phase 2)Looking for participantsNCT06042569
What this trial is testing

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more
City of Hope Medical Center 174
Very early researchWithdrawnNCT01302002
What this trial is testing

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Who this might be right for
Breast Cancer
Instituto Nacional de Cancer, Brazil
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07394946
What this trial is testing

Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.

Who this might be right for
Hormone Receptor-Positive, HER2-Negative, Node Positive Breast Cancer
Cancer Care Hospital & Research Centre Foundation, Lahore 126
Post-approval studies (Phase 4)Looking for participantsNCT04790305
What this trial is testing

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Who this might be right for
Carcinoma BreastTriple-negative Breast CancerInvasive Ductal Carcinoma, Breast
Fudan University 1,072
Testing effectiveness (Phase 2)Study completedNCT01266486
What this trial is testing

Effect of Metformin on Breast Cancer Metabolism

Who this might be right for
Breast Cancer
Oxford University Hospitals NHS Trust 41
Next Page